Download App

Log in to access Online Inquiry
Company Overview More
Sihuan Pharmaceutical holding Group Co., Ltd. is a Hong Kong investment holding company engaged in pharmaceutical business. The company is mainly engaged in drug research and development, manufacturing and sales in China. Its products cover cardio-cerebrovascular, central nervous system, metabolism, tumor and anti-infection fields. Its products include cardiovascular and cerebrovascular products such as Klingo, Agili and Odime, as well as non-cardiovascular and cerebrovascular products such as Renao, metronidazole and roxatidine.
CEO: Fengsheng Che
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

00460 SIHUAN PHARM
1.220-0.010-0.81%
YOY
Do not show
Hide blank lines
(FY)2021/12/31(Q6)2021/06/30(FY)2020/12/31(Q6)2020/06/30
Assets
Current assets
Inventory
44.25% 715.3M 28.65% 565.71M 21.07% 495.89M 20.44% 439.71M
Accounts receivable
27.06% 1.23B 86.01% 1.29B 54.19% 971.54M -14.85% 694.15M
Cash and equivalents
23.42% 5.68B -6.41% 4.63B -10.03% 4.6B 0.23% 4.95B
Financial assets at fair value-current assets
-67.14% 109.3M 61.39% 679.23M 124.28% 332.68M -25.14% 420.85M
Special items of current assets
-- -- -- -- -- -- -- 441.9M
Total current assets
20.88% 7.74B 3.2% 7.17B 1.57% 6.4B 3.97% 6.94B
Non-current assets
Property, plant and equipment
8.24% 3.3B 11.43% 3.15B 11.8% 3.05B 1.85% 2.82B
Investment property
-3.4% 224.27M -0.26% 228.59M -0.27% 232.17M -1.37% 229.19M
Secured deposits-non-current assets
0.06% 144.63M -- 144.55M -- 144.55M -- --
Financial assets at fair value-non-current assets
36.12% 267M 65.02% 273.48M 12.59% 196.15M -12.43% 165.72M
Intangible assets
17.86% 595.92M 15.91% 639.78M 5.34% 505.62M -54.71% 551.98M
Goodwill
130.28% 28.35M 413.22% 44.96M -- 12.31M -- 8.76M
Deferred tax assets
12.62% 303.46M 6.71% 312.95M -18.89% 269.45M -14.16% 293.27M
Other illiquid assets
6.64% 392.3M 43.51% 459.58M 8.64% 367.87M 4.96% 320.25M
Special items of non-current assets
-19.64% 1.49B 6.08% 1.89B -6.02% 1.86B 50.16% 1.78B
Total non-current assets
1.72% 6.75B 15.64% 7.14B 5.96% 6.64B -12.86% 6.17B
Total assets
11.13% 14.5B 9.06% 14.31B 3.76% 13.04B -4.69% 13.12B
Liabilities
Current liabilities
Accounts payable
7.71% 1.97B -28.68% 2.1B -3.97% 1.83B 31.54% 2.94B
Tax payable
395.64% 111.25M 426.29% 197.7M 59.94% 22.45M -70.65% 37.57M
Bank loans and overdrafts
-48.44% 200M -71.64% 146.07M -- 387.93M -- 514.98M
Financial lease liabilities-current liabilities
260.37% 5.19M 58.97% 1.82M -64.49% 1.44M -72.89% 1.14M
Other current liabilities
-46.95% 7.68M -42.59% 6.03M 36.58% 14.48M 61.6% 10.5M
Special items of current liabilities
10.61% 206.43M -45.59% 156.95M -42.8% 186.63M -12.77% 288.44M
Total current liabilities
2.4% 2.5B -31.3% 2.61B 8.06% 2.44B 40.23% 3.79B
Net current assets
32.28% 5.24B 44.78% 4.56B -2.06% 3.96B -20.72% 3.15B
Total assets less current liabilities
13.14% 11.99B 25.49% 11.7B 2.81% 10.6B -15.68% 9.32B
Non-current liabilities
Long-term bank loan
145.56% 813.22M 814.08% 665.86M -- 331.17M -- 72.85M
Financial lease liabilities-non-current liabilities
1153.51% 31.46M -20.72% 1.59M -57.4% 2.51M -69.98% 2.01M
Deferred tax liability
-1.46% 222.39M 26.16% 271.42M -20.14% 225.69M -13.17% 215.13M
Other non-current liabilities
1804.9% 1.77B -21.65% 71.81M 16.4% 92.74M 22.39% 91.66M
Special items of non-current liabilities
-- 9.97M -- 8.49M -- -- -- --
Total non-current liabilities
336.08% 2.84B 167.05% 1.02B 76.98% 652.12M 14.41% 381.64M
Total liabilities
72.7% 5.35B -13.18% 3.63B 17.72% 3.1B 37.4% 4.18B
Total assets less total liabilities
-8.03% 9.15B 19.44% 10.68B 0.07% 9.95B -16.62% 8.94B
Total equity and non-current liabilities
13.14% 11.99B 25.49% 11.7B 2.81% 10.6B -15.68% 9.32B
Equity
Share capital
-1.44% 77.06M -0.15% 78.07M 0% 78.19M 0% 78.19M
Share premium
-4.96% 3.88B -0.71% 4.06B 0% 4.08B 0% 4.08B
Other reserves
-130.53% -221.44M 392.42% 918.19M 276.4% 725.22M 14.35% 186.47M
Retained profit
5.67% 4.55B 12.08% 4.79B -18.07% 4.3B -29.18% 4.27B
Shareholders' Equity
-9.86% 8.28B 14.13% 9.84B -4.33% 9.19B -16.77% 8.62B
Non-controlling interest
14.18% 865.92M 163.97% 836.78M 126.04% 758.38M -12.18% 317M
Total equity
-8.03% 9.15B 19.44% 10.68B 0.07% 9.95B -16.62% 8.94B
Total equity and total liabilities
11.13% 14.5B 9.06% 14.31B 3.76% 13.04B -4.69% 13.12B
Currency Unit
CNYCNYCNYCNY
Accounting Standards
IASIASIASIAS
Audit Opinions
Unqualified Opinion--Unqualified Opinion--
Auditor
Ernst & Young accounting firm--Ernst & Young accounting firm--

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%